市場調査レポート
商品コード
1410818
尿管鏡市場:セグメント別規模、シェア、法規制、償還、手技、設置ベース、2033年までの予測Ureteroscopes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures, Installed Base and Forecast to 2033 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
尿管鏡市場:セグメント別規模、シェア、法規制、償還、手技、設置ベース、2033年までの予測 |
出版日: 2023年12月15日
発行: GlobalData
ページ情報: 英文
納期: 即納可能
|
尿管鏡の市場規模は、高齢化人口の増加、腎結石患者の増加、腎臓・尿管・膀胱のその他の疾患など、さまざまな要因によって牽引されています。
世界の泌尿器疾患人口は増加の一途をたどっており、世界中で2億人以上が腎臓疾患を患っていると推定されています。尿管鏡は、これらの患者に薬剤を投与するために使用される機器です。このような泌尿器疾患の患者数の増加により、尿管鏡を必要とする病院が増加し、尿管鏡市場の拡大が見込まれています。
当レポートは、世界の尿管鏡市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。
Not Applicable
Not Applicable
Ureteroscopes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures, Installed Base and Forecast to 2033 is built to visualize quantitative market trends within Endoscopy Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Ureteroscopes market for the year 2020 and beyond. The Ureteroscopes market is driven by a variety of factors, including a growing aging population, increase in patients with kidney stones, and other conditions of the kidney, ureter, and bladder.
The global population with urological disorders continues to increase with more than 200 million people worldwide estimated to have kidney disorders. Ureteroscopes are devices used to administer medication to these patients. This rising number of patients with urological disorders is expect to result in a larger number of hospitals that require Ureteroscopes, resulting in an increase in the market for Ureteroscopes.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Ureteroscopes and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: KARL STORZ SE & Co KG, Hoya Corp, Olympus Corp, National Advanced Endoscopy Devices, Inc., Richard Wolf GmbH, Stryker Corp, Boston Scientific Corp, NeoScope Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable